Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services BENGALURU, India, Oct. 27, 2025 /PRNewswire/ -- Syngene International, a global contract ...
VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...
Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes. This partnership aims to broaden VivaMed’s validation ...
Johnson & Johnson expands its Tar Heel State presence with $2 billion investment, and Syngene sites first U.S. facility in Baltimore. Johnson & Johnson is expanding its footprint in North Carolina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results